Level Biotechnology (3118) — Financial Flexibility Index
Level Biotechnology (3118) has a Financial Flexibility Index of 0.07x as of September 2025. Free cash flow of NT$16.26 Million (operating CF NT$11.81 Million minus capex NT$4.44 Million) represents 0% of total liabilities (NT$237.03 Million). Check Level Biotechnology (3118) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Level Biotechnology Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Level Biotechnology across 8 annual periods. See working capital to net assets of Level Biotechnology to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Level Biotechnology (2017–2024)
Year-by-year free cash flow to debt coverage for Level Biotechnology. For the full company profile including market capitalisation, see 3118 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.08x | NT$287.77 Million | NT$64.10 Million | NT$267.19 Million | ▲ +277.8% |
| 2023 | 0.29x | NT$77.88 Million | NT$70.21 Million | NT$273.20 Million | ▲ +7.2% |
| 2022 | 0.27x | NT$71.81 Million | NT$65.07 Million | NT$270.13 Million | ▼ -60.9% |
| 2021 | 0.68x | NT$165.10 Million | NT$155.95 Million | NT$242.78 Million | ▲ +93.1% |
| 2020 | 0.35x | NT$85.77 Million | NT$83.23 Million | NT$243.56 Million | ▼ -25.3% |
| 2019 | 0.47x | NT$111.45 Million | NT$109.02 Million | NT$236.43 Million | ▲ +192.3% |
| 2018 | 0.16x | NT$29.29 Million | NT$26.77 Million | NT$181.60 Million | ▼ -58.8% |
| 2017 | 0.39x | NT$82.12 Million | NT$71.29 Million | NT$210.03 Million | — |